Impact of triple transmembrane regulator therapy on glucose metabolism in cystic fibrosis related diabetes during clinical practice-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Impact of triple transmembrane regulator therapy on glucose metabolism in cystic fibrosis related diabetes during clinical practice

Published:2024-10 Issue: Volume:216 Page:111839
ISSN:0168-8227
Container-title:Diabetes Research and Clinical Practice
language:en
Short-container-title:Diabetes Research and Clinical Practice

Author:

Aguilera García I.,García Moreno R.M.,López Plaza B.,Barquiel Alcalá B.,Vázquez Pérez P.,Barreda Bonis A.C.,Zamarrón de Lucas E.,Palma Milla S.,Prados Sánchez M.C.,González Pérez de Villar N.

Publisher

Elsevier BV

Reference21 articles.

1. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: A technical review;Moran;Diabetes Care,2010

2. Cystic fibrosis-related diabetes;Kayani;Front Endocrinol (Lausanne),2018

3. Early glucose abnormalities are associated with pulmonary inflammation in young children with cystic fibrosis;Prentice;J Cyst Fibros,2019

4. Grasemann H, Ratjen F. Cystic Fibrosis. Taichman DB, editor. New England Journal of Medicine [Internet]. 2023 Nov 2;389(18):1693–707. Available from: http://www.nejm.org/doi/10.1056/NEJMra2216474.

5. VX-659–Tezacaftor–Ivacaftor in patients with cystic fibrosis and one or two Phe508del Alleles;Davies;N Engl J Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP